CORMORANT ASSET MANAGEMENT, LP – Rocket Pharmaceuticals, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$13.86M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+15.99%
quarter
Rocket Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.91M | $15.96 | 868.55K | |
| Q2 2022 | share | 0.00% | 0 shares | -1.82M | $13.76 | 868.55K | |
| Q1 2022 | share | 0.00% | 0 shares | -5.18M | $15.86 | 868.55K | |
| Q4 2021 | share | Decrease | -10.32% | -100K shares | -9.99M | $22.93 | 868.55K |
| Q3 2021 | share | 0.00% | 0 shares | -13.94M | $29.89 | 968.55K | |
| Q2 2021 | share | Decrease | -29.23% | -400K shares | -17.82M | $44.29 | 968.55K |
| Q1 2021 | share | 0.00% | 0 shares | -14.32M | $44.37 | 1.36M | |
| Q4 2020 | share | 0.00% | 0 shares | 43.76M | $54.84 | 1.36M | |
| Q3 2020 | share | Decrease | -6.81% | -100K shares | 548K | $22.86 | 1.36M |
| Q2 2020 | share | Decrease | -6.38% | -100K shares | 8.85M | $20.93 | 1.46M |
| Q1 2020 | share | Decrease | -14.63% | -268.71K shares | -19.93M | $13.95 | 1.56M |
| Q4 2019 | share | Decrease | -13.49% | -286.49K shares | 17.07M | $22.76 | 1.83M |
| Q3 2019 | share | Increase | +2.37% | 49.16K shares | -6.37M | $11.65 | 2.12M |
| Q2 2019 | share | Increase | +22.04% | 374.59K shares | 1.30M | $15 | 2.07M |
| Q1 2019 | share | Decrease | -12.63% | -245.65K shares | 983K | $17.54 | 1.7M |
| Q4 2018 | share | Increase | +29.65% | 445K shares | -8.11M | $14.82 | 1.94M |
| Q3 2018 | share | Decrease | -1.27% | -19.23K shares | 7.11M | $24.62 | 1.50M |
| Q2 2018 | share | Decrease | -0.00% | -1 shares | 1.33M | $19.63 | 1.51M |
| Q1 2018 | share | Increase | 0.00% | 1.51M shares | 28.49M | $18.75 | 1.51M |